GLI1-rearranged enteric tumors are a newly proposed category of mesenchymal neoplasms, most commonly found in the gastrointestinal tract, and are defined by rearranging the GLI1 gene at chromosome 12q13.3 with various pathogenic fusion partners, most commonly ACTB::GLI1 and MALAT1::GLI1 [1]. This evidence concerns the gene GLI1 and mesenchymal cell neoplasm.